Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial.
Study type and population - Open-label, international, multicenter phase 2 trial. - Previously untreated metastatic...
Endoscopic ultrasound versus endoscopic retrograde cholangiopancreatography for primary palliation of malignant distal biliary obstruction: a cost-effectiveness modeling analysis.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
Study type - Decision-analytic, state-transition Markov model over 1 year - US healthcare payer perspective - Popu...
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
Phase 2 POLAR was a biomarker-stratified maintenance trial of pembrolizumab plus olaparib in metastatic pancreatic cance...
Systemic Therapy for Advanced Pancreatic Cancer in 2025: Current Standard-of-Care and Emerging Therapeutic Strategies.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This publication is a narrative review of current and emerging systemic treatments for advanced pancreatic cancer, with...
Long Term and Oncologic Outcomes for Patients Receiving Piperacillin-Tazobactam or Cefoxitin as Antibiotic Prophylaxis for Pancreatoduodenectomy.
- Post category:Digestive (CRC, Stomach) System
- Reading time:2 mins read
Study question Does using broad-spectrum perioperative prophylaxis with piperacillin-tazobactam (PTZ), compared with c...
PanMETAI – a high performance tabular foundation model for accurate pancreatic cancer diagnosis via NMR metabolomics.
- Post category:Digestive (CRC, Stomach) System
- Reading time:1 min read
This study develops and evaluates a serum-based metabolomics plus AI platform to improve early detection of pancreatic d...